Boflox flavour, 80mg, oral tablet for dogs
Boflox flavour, 80mg, oral tablet for dogs
Authorised
- Marbofloxacin
Product identification
Medicine name:
Boflox flavour, 80mg, oral tablet for dogs
Active substance:
- Marbofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Marbofloxacin80.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- box containing 240 tablets (40 blister)
- box containing 120 tablets (20 blister)
- box containing 72 tablets (12 blister)
- box containing 36 tablets (6 blister)
- box containing 12 tablets (2 blister)
- box containing 6 tablets (1 blister)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 489/05-01-2022/K-0219902
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0330/002
Concerned member states:
-
Austria
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
eu-PUAR-esv0330002-dcp-boflox-flavour--80mg--oral-tablet-for-dogs-en.pdf
English (PDF)
Download Published on: 22/12/2023
